Valuation Inter Pharma Thailand S.E.

Stocks

End-of-day quote Thailand S.E. 22/10/2026			5-day change	1st Jan Change
4.920 ^THB	-0.40%		+2.07%	+6.96%

07/10	Inter Pharma Public Company Limited Announces Board and Committee Changes	CI
14/08	Inter Pharma Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	2,699	5,811	5,513	3,353	1,949	2,785
Change	-	115.34%	-5.13%	-39.19%	-41.86%	42.86%
Enterprise Value (EV) ¹	2,666	5,993	5,275	3,339	2,158	2,904
Change	-	124.78%	-11.98%	-36.69%	-35.37%	34.56%
P/E	50.2x	54.2x	40.6x	66x	52.3x	22.8x
PBR	5.73x	7.63x	2.86x	1.75x	1.01x	1.35x
PEG	-	0.6x	33.47x	-1.1x	-2x	0x
Capitalization / Revenue	6.04x	6.31x	3.59x	1.86x	1.02x	1.26x
EV / Revenue	5.97x	6.51x	3.44x	1.86x	1.13x	1.31x
EV / EBITDA	32.4x	35x	25.3x	19.9x	15.6x	10.7x
EV / EBIT	34x	41.1x	30.7x	30.5x	28.6x	15.1x
EV / FCF	112x	-18.9x	134x	-63.8x	-22.3x	31.7x
FCF Yield	0.89%	-5.3%	0.75%	-1.57%	-4.48%	3.16%
Dividend per Share ²	0.0103	-	0.1108	0.0214	-	0.073
Rate of return	0.18%	-	1.22%	0.39%	-	1.59%
EPS ²	0.1147	0.2214	0.2241	0.0839	0.0616	0.2022
Distribution rate	8.98%	-	49.4%	25.5%	-	36.1%
Net sales ¹	446.9	921	1,534	1,799	1,912	2,214
EBITDA ¹	82.3	171.4	208.7	167.7	138.3	272.5
EBIT ¹	78.5	145.8	171.7	109.4	75.53	192
Net income ¹	53.78	105.2	119.2	50.79	37.28	122.4
Net Debt ¹	-32.53	181.5	-238.3	-13.3	208.9	119.3
Reference price ²	5.758	12.000	9.108	5.538	3.220	4.600
Nbr of stocks (in thousands)	4,68,650	4,84,267	6,05,346	6,05,346	6,05,344	6,05,344
Announcement Date	25/02/21	25/02/22	28/02/23	01/03/24	25/02/25	02/03/26

¹THB in Million²THB

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,13500Cr
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	64TCr
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	50TCr
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	38TCr
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	36TCr
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	29TCr
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	27TCr
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	24TCr
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	19TCr
Average	29.46x	7.04x	18.70x	2.12%	44.49TCr
Weighted average by Cap.	35.14x	8.29x	20.39x	1.8%